Efficacy and metabolic outcomes of DOR/TDF/3TC versus BIC/TAF/FTC in overweight, treatment-naïve people living with HIV: 24-week results from the COATL randomized trial (HIV-Glasgow 2026) - Oct 24, 2026 - Abstract #P434; No abstract available
Clinical • Human Immunodeficiency Virus • Infectious Disease • Obesity
|
|
Ana Luz Cano Díaz; Mitzi Daniela Ramírez Ramírez; Paola Edith Padilla Noguera; José Antonio Mata Marín; Gloria Elizabeth Salinas Velázquez; Emily Pecero García; Alberto Chaparro Sánchez; Ericka Nelly Pompa Mera; Jesús Enrique Gaytán Martínez
|